This is a long, detailed and thoroughly referenced article. If you're a tl;dr type, the short answer is Yes.
Perhaps you saw the headlines."Evolocumab significantly reduces risk of cardiovascular events." Science Daily1Very impressive at first glance, but what are those lines from Gilbert & Sullivan's HMS Pinafore?
"New drug shows promise in preventing heart attacks." NHS Choices2
"Evolocumab Added to Statins Cuts CV Events." Medscape3Things are seldom what they seem,As it turns out, when we look at the study in question, it seems that we may have been Pinafored.
Skim milk masquerades as cream;
So they do.
Read more: https://jonbarron.org/heart-health/c...ol-go-too-low#